| 摘要 |
The invention is directed to compounds of formulae (I), (II) and (III), wherein A, R1, R2, R3, R4, X, Y and W are set forth in the specification, as well as solvates, hydrates, tautomers or pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. |
| 申请人 |
3-DIMENSIONAL PHARMACEUTICALS, INC.;PLAYER, MARK, R.;BAINDUR, NAND;BRANDT, BENJAMIN, M.;CHADHA, NARESH;PATCH, RAYMOND, J.;ASGARI, DAVOUD;GEORGIADIS, TAXIARCHIS |
发明人 |
PLAYER, MARK, R.;BAINDUR, NAND;BRANDT, BENJAMIN, M.;CHADHA, NARESH;PATCH, RAYMOND, J.;ASGARI, DAVOUD;GEORGIADIS, TAXIARCHIS |
